Candel Therapeutics, Inc. (CADL) Financials
CADL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 208.1 million | 82.0 million |
| March 31, 2026 | 201.9 million | 63.9 million |
| Dec. 31, 2025 | 125.2 million | 73.3 million |
| Sept. 30, 2025 | 93.6 million | 13.5 million |
CADL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -17.3 million | 2.9 million |
| March 31, 2026 | -18.7 million | 1.5 million |
| Dec. 31, 2025 | -11.0 million | 1.3 million |
| Sept. 30, 2025 | -10.4 million | 1.2 million |
CADL Net Income
No data available :(
CADL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 201.6 million | - | - |
| March 31, 2026 | 194.8 million | - | 1.8 million |
| Dec. 31, 2025 | 119.7 million | - | 1.9 million |
| Sept. 30, 2025 | 87.0 million | - | 2.0 million |
CADL Shares Outstanding
CADL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 69000 | 19.8 million | 6.9 million | - |
| March 31, 2026 | 675000 | 9.8 million | 6.4 million | - |
| Dec. 31, 2025 | 409000 | 11.0 million | 4.7 million | - |
| Sept. 30, 2025 | 144000 | 8.5 million | 4.7 million | - |
CADL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 149000 |
| Dec. 31, 2025 | - | 163000 |
| Sept. 30, 2025 | - | 195000 |
CADL
Price: $10.32
52 week price:
Earnings Per Share: -1.46 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14500
Market Capitalization: 936.4 million